{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:30:06Z","timestamp":1793446206147,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073226"],"award-info":[{"award-number":["82073226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbadis.2024.167628","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T17:36:36Z","timestamp":1734284196000},"page":"167628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["High MICAL-L2 promotes cancer progression and drug resistance in renal clear cell carcinoma cells through stabilization of ACTN4 following vimentin expression"],"prefix":"10.1016","volume":"1871","author":[{"given":"Weizhen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiang","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167628_bb0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2024.167628_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/fon-2016-0355","article-title":"Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma","volume":"13","author":"Czarnecka","year":"2017","journal-title":"Future Oncol."},{"key":"10.1016\/j.bbadis.2024.167628_bb0015","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1089\/ars.2013.5487","article-title":"MICAL-family proteins: complex regulators of the actin cytoskeleton","volume":"20","author":"Giridharan","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2024.167628_bb0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s12885-022-09614-0","article-title":"High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2024.167628_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010518","article-title":"Comprehensive analysis of MICALL2 reveals its potential roles in EGFR stabilization and ovarian cancer cell invasion","volume":"25","author":"Xia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2024.167628_bb0030","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1111\/jcmm.14353","article-title":"MICAL-L2 potentiates Cdc42-dependent EGFR stability and promotes gastric cancer cell migration","volume":"23","author":"Min","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2024.167628_bb0035","article-title":"MICAL-L2 is essential for c-Myc deubiquitination and stability in non-small cell lung cancer cells","volume":"8","author":"Min","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2024.167628_bb0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12964-022-00984-3","article-title":"MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer","volume":"20","author":"Wen","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbadis.2024.167628_bb0045","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7150\/jca.66922","article-title":"Identification of MICALL2 as a novel prognostic biomarker correlating with inflammation and T cell exhaustion of kidney renal clear cell carcinoma","volume":"13","author":"Lin","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167628_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167124","article-title":"PlexinA1 promotes gastric cancer migration through preventing MICAL1 protein ubiquitin\/proteasome-mediated degradation in a Rac1-dependent manner","volume":"1870","author":"Ye","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2024.167628_bb0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3892\/or.2020.7615","article-title":"Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma","volume":"44","author":"Wang","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2024.167628_bb0060","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1432-1033.2004.04095.x","article-title":"Actin-binding domain of mouse plectin. Crystal structure and binding to vimentin","volume":"271","author":"Sevcik","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bbadis.2024.167628_bb0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bbrc.2019.12.084","article-title":"The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer","volume":"523","author":"Ishizuya","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2024.167628_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13578-015-0031-0","article-title":"The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer","volume":"5","author":"Honda","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbadis.2024.167628_bb0075","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1128\/MCB.00144-08","article-title":"Involvement of actinin-4 in the recruitment of JRAB\/MICAL-L2 to cell-cell junctions and the formation of functional tight junctions","volume":"28","author":"Nakatsuji","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2024.167628_bb0080","article-title":"CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation","volume":"15","author":"Liu","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2024.167628_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0076-6879(07)38010-5","article-title":"Identification and characterization of JRAB\/MICAL-L2, a junctional Rab13-binding protein","volume":"438","author":"Nishimura","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2024.167628_bb0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","article-title":"SnapShot: TCGA-analyzed tumors","volume":"173","author":"Blum","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2024.167628_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.bbadis.2024.167628_bb0100","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1186\/s12885-022-10462-1","article-title":"High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2024.167628_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.33160\/yam.2023.02.021","article-title":"Micall2 is responsible for the malignancy of clear cell renal cell carcinoma","volume":"66","author":"Zeng","year":"2023","journal-title":"Yonago Acta Med. Austriaca"},{"key":"10.1016\/j.bbadis.2024.167628_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4062\/biomolther.2017.033","article-title":"Cellular prion protein enhances drug resistance of colorectal Cancer cells via regulation of a survival signal pathway","volume":"26","author":"Lee","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.bbadis.2024.167628_bb0115","first-page":"9233","article-title":"E2F1-directed activation of nc886 mediates drug resistance in cervical cancer cells via regulation of major vault protein","volume":"10","author":"Li","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2024.167628_bb0120","doi-asserted-by":"crossref","unstructured":"Y. Zhu, K. Liu, D. Ding, L. Peng, First-line Lenvatinib plus Pembrolizumab or Everolimus versus Sunitinib for advanced renal cell carcinoma: a United States-based cost-effectiveness analysis, Clin. Genitourin. Cancer, 21 (2023) 417 e411\u2013417 e410. doi:https:\/\/doi.org\/10.1016\/j.clgc.2022.11.014.","DOI":"10.1016\/j.clgc.2022.11.014"},{"key":"10.1016\/j.bbadis.2024.167628_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2021.08.046","article-title":"Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: a retrospective study of the GETUG group (Groupe d\u2019Etude des Tumeurs Uro-Genitales)","volume":"158","author":"Cancel","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167628_bb0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euo.2019.06.018","article-title":"Metastatic renal cell carcinoma rapidly progressive to Sunitinib: what to do next?","volume":"4","author":"Bersanelli","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.bbadis.2024.167628_bb0135","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/mp.2017.74","article-title":"A new locus regulating MICALL2 expression was identified for association with executive inhibition in children with attention deficit hyperactivity disorder","volume":"23","author":"Yang","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbadis.2024.167628_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109730","article-title":"MICALL2 participates in the regulation of epithelial-mesenchymal transition in alveolar epithelial cells - potential roles in pulmonary fibrosis","volume":"747","author":"Chen","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2024.167628_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116256","article-title":"MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the AKT\/mTOR pathway","volume":"225","author":"Wen","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167628_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111427","article-title":"Role of ACTN4 in tumorigenesis, metastasis, and EMT","volume":"8","author":"Tentler","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2024.167628_bb0155","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1111\/cas.15841","article-title":"Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma","volume":"114","author":"Kawamura","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2024.167628_bb0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1091\/mbc.E15-05-0319","article-title":"A complex of Rab13 with MICAL-L2 and alpha-actinin-4 is essential for insulin-dependent GLUT4 exocytosis","volume":"27","author":"Sun","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbadis.2024.167628_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10555-023-10154-7","article-title":"Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance","volume":"43","author":"Tabatabaee","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"2023","key":"10.1016\/j.bbadis.2024.167628_bb0170","article-title":"Tumor-derived vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T-cell-inflamed phenotype in small cell lung cancer","volume":"4","author":"Deng","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bbadis.2024.167628_bb0175","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1038\/s41598-019-49232-8","article-title":"Actin cytoskeletal reorganization function of JRAB\/MICAL-L2 is fine-tuned by intramolecular interaction between first LIM zinc finger and C-terminal coiled-coil domains","volume":"9","author":"Miyake","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2024.167628_bb0180","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s12253-020-00809-z","article-title":"Survival benefits of second-line Axitinib versus Everolimus after first line Sunitinib treatment in metastatic renal cell carcinoma","volume":"26","author":"Geczi","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbadis.2024.167628_bb0185","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1470-2045(22)00212-1","article-title":"Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study","volume":"23","author":"Motzer","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2024.167628_bb0190","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/ijc.32256","article-title":"Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer","volume":"145","author":"Elgendy","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167628_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41388-021-02101-z","article-title":"Phosphorylation of MICAL2 by ARG promotes head and neck cancer tumorigenesis by regulating skeletal rearrangement","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924006227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924006227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:07:36Z","timestamp":1772456856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924006227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0925443924006227"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167628","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High MICAL-L2 promotes cancer progression and drug resistance in renal clear cell carcinoma cells through stabilization of ACTN4 following vimentin expression","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167628"}}